Bixiye
QP70-22 New Forms for Children’s Residential Treatment Admissions and Continued Stay Requests
Taariikhda barnaamijka Dhaqangalayso Agosto 24, 2022
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1871 - 1880 ee natiijooyinka 3167
Bixiye
QP71-22 Blue Cross Basics Webinar: Focus on Mental Health & Substance Use Disorder Providers
Taariikhda barnaamijka Dhaqangalayso Agosto 24, 2022
Bixiye
QP69-22 Skilled Nursing Facility (SNF) Benefit Information for Medicare Advantage
Taariikhda barnaamijka Dhaqangalayso Agosto 10, 2022
Bixiye
QP64-22 EquiClaim Expanding Hospital Bill Validation Services
Taariikhda barnaamijka Dhaqangalayso Agosto 10, 2022
Bixiye
QP67-22 MHCP Pharmacy Benefit Exclusion for Amvuttra™, Pemetrexed, and Skyrizi®
Taariikhda barnaamijka Dhaqangalayso Agosto 10, 2022
Bixiye
QP68-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2022
Taariikhda barnaamijka Dhaqangalayso Agosto 10, 2022
Bixiye
QP65-22 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda barnaamijka Dhaqangalayso Agosto 10, 2022
Bixiye
QP66-22 Commercial Pharmacy Benefit Exclusion for Amvuttra™ and Skyrizi®
Taariikhda barnaamijka Dhaqangalayso Agosto 10, 2022
Bixiye
P7R1-21 Change in Liability for Members of Other Blue Plans
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2022
Bixiye
P43-22 Updated Laboratory Services: General Guide Reimbursement Policy
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2022